TCF7L2 and nonpapillary renal cell carcinoma: In addition, the CCK-8 assay demonstrated that the TPM3P9-mediated proliferative phenotype of ccRCC cells was inhibited by the silencing of TCF7L2-L, SAM68, or RELB (Fig. 8p).